Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and Gut Microbiome in ASCVD
NCT04215237Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Nov 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of atorvastatin in atherosclerotic cardiovascular disease (ASCVD), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Number of flora at 4 months. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT04215237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04215237.